# metaLinear

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/metalinear

- Industry: Biotechnology
- Headquarters: Cheshire, UK
- Website: www.metalinear.co.uk
- Total disclosed funding: $0.3M
- Latest round: Seed (Nov 8, 2017)
- Investors on record: 3

## About

metaLinear Ltd specializes in delivering innovative technology solutions aimed at enhancing operational efficiency across various industries, particularly in healthcare, finance, and manufacturing.Founded in 2017 by Paul Ko Ferrigno and headquartered in Cheshire, UK, metaLinear Ltd operates as an independent company and has undergone no significant pivots in business strategy. The company successfully raised GBP 0.26 mn in a SEED funding round on November 8, 2017, from investors including Alderley Park Ventures, Mobius Life Sciences, and Catapult Ventures, achieving a post-money valuation of GBP 0.60 mn.metaLinear Ltd offers a range of innovative products and services designed to address specific needs across various industries. Its core offerings include advanced technology solutions that enhance operational efficiency and improve user experience, targeting sectors such as healthcare, finance, and manufacturing. The company provides end users with tools that streamline processes, reduce costs, and elevate service quality, strategically launching these solutions within North America and Europe for medium to large enterprises and small businesses.The company generates revenue through a structured model that includes direct sales of its flagship products and services, alongside subscription-based offerings. Transactions typically occur through business-to-business partnerships, where clients engage with the company to obtain tailored solutions that meet their specific requirements. Clients may subscribe to service plans for ongoing access to software updates and support, ensuring maximum value from their investment. This revenue model ensures steady cash flow while fostering long-term client relationships.metaLinear Ltd aims to leverage its recent funding of GBP 0.26 mn raised in November 2017 to support its product development initiatives. The funding will be utilized to design and launch upcoming innovative technology solutions tailored to meet the evolving needs of its clients. Additionally, the company plans to expand into new geographical markets, specifically targeting further penetration in North America and Europe within the next two years. This strategy is designed to enhance the company's market presence and drive sustainable growth.

## Funding rounds

- Seed, Nov 8, 2017, $0.3M — Mobius Life Sciences, Alderley Park Ventures, Catapult

## Investors

- Mobius Life Sciences (https://capitalatlas.ai/funds/mobius-life-sciences) — Seed
- Alderley Park Ventures — Seed
- Catapult — Seed